Skip to main content
OpenTrials
Completed

NCT Number: NCT01788488

Procalcitonin Use in Pneumonia Patients in the Critical Care Setting

The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pneumonia Infections Lung Diseases Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic Health System Eau Claire

Eau Claire, Wisconsin, 54702, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years old
  • admitted to critical care unit
  • placed on pneumonia protocol

Exclusion criteria

  • patients who received outpatient antibiotic therapy within previous 21 days

Treatment and study plan

Use of procalcitonin as biomarker to guide therapy

Other

Primary outcomes

  1. Length of antibiotic therapy

    Time frame: Indefinite

    Participants will be followed for the entire time they are on antibiotics to treat pneumonia, an expected average of 30 total antibiotic days.

Secondary outcomes

  1. Length of stay in critical care unit

    Time frame: Indefinite

    Participants will be followed for their entire length of stay in the critical care unit, an expected average of 7 days.

  2. Cost

    Time frame: Once

    The average cost of antibiotics per patient, measured in US dollars, based on total antibiotic days.

  3. Length of stay in the hospital

    Time frame: Indefinite

    Participants will be followed their entire length of stay in the hospital, an expected average of 14 days.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Impact of Measuring Serum Procalcitonin Levels on Duration of Antimicrobial Therapy in Critical Care Patients With Suspected Pneumonia

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Feb 11, 2013
Registry last updated
Jun 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.